Geode Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-236,757
| Closed | -$4.25M | – | 4126 |
|
|
2017
Q4 | $4.25M | Sell |
236,757
-31,957
| -12% | -$393K | ﹤0.01% | 2305 |
|
|
2017
Q3 | $3.17M | Sell |
268,714
-15,583
| -5% | -$175K | ﹤0.01% | 2474 |
|
|
2017
Q2 | $2.98M | Buy |
284,297
+4,294
| +2% | +$43.8K | ﹤0.01% | 2497 |
|
|
2017
Q1 | $3.08M | Sell |
280,003
-29,030
| -9% | -$337K | ﹤0.01% | 2402 |
|
|
2016
Q4 | $4.19M | Buy |
309,033
+86,656
| +39% | +$1.21M | ﹤0.01% | 2179 |
|
|
2016
Q3 | $2.74M | Buy |
222,377
+5,847
| +3% | +$68.9K | ﹤0.01% | 2361 |
|
|
2016
Q2 | $2.37M | Sell |
216,530
-5,803
| -3% | -$65K | ﹤0.01% | 2368 |
|
|
2016
Q1 | $2.43K | Buy |
222,333
+9,433
| +4% | +$119K | ﹤0.01% | 2336 |
|
|
2015
Q4 | $3.68M | Sell |
212,900
-8,048
| -4% | -$144K | ﹤0.01% | 2086 |
|
|
2015
Q3 | $4.39M | Buy |
220,948
+12,713
| +6% | +$291K | ﹤0.01% | 1920 |
|
|
2015
Q2 | $3.42M | Buy |
208,235
+31,767
| +18% | +$551K | ﹤0.01% | 2158 |
|
|
2015
Q1 | $2.75M | Buy |
176,468
+26,505
| +18% | +$411K | ﹤0.01% | 2241 |
|
|
2014
Q4 | $2.14M | Buy |
149,963
+1,240
| +0.8% | +$13.1K | ﹤0.01% | 2383 |
|
|
2014
Q3 | $966K | Sell |
148,723
-14,125
| -9% | -$93.8K | ﹤0.01% | 2795 |
|
|
2014
Q2 | $1.12M | Sell |
162,848
-14,861
| -8% | -$105K | ﹤0.01% | 2734 |
|
|
2014
Q1 | $1.27M | Buy |
177,709
+38,021
| +27% | +$325K | ﹤0.01% | 2633 |
|
|
2013
Q4 | $1.31M | Sell |
139,688
-31,453
| -18% | -$224K | ﹤0.01% | 2548 |
|
|
2013
Q3 | $1.07M | Buy |
171,141
+2,368
| +1% | +$14.8K | ﹤0.01% | 2553 |
|
|
2013
Q2 | $1.11M | Buy |
+168,773
| New | +$1.34M | ﹤0.01% | 2404 |
|
Other funds holding SCMP
Geode Capital Management's SCMP Position: Q1 2018 in Review
Geode Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 236,757 shares — an estimated $4.25M sold.
Geode Capital Management first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $4.39M in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Geode Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Geode Capital Management sold 236,757 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $4.25M.
- Geode Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- Geode Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $4.39M in Q3 2015.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Geode Capital Management's 13F filing for Q1 2018, filed 15 May 2018.